Drug Trial Radar · NCT05579548
A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding
Last checked: Nov 20, 2026Latest source record: Mar 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Nov 22, 2022
Primary completion
Oct 4, 2032
Study completion Oct 4, 2032
Sponsor
- Lead sponsor
- BioMarin PharmaceuticalBioMarin (BMRN)
- Sponsor type
- Industry
- Collaborators
- Syneos Health
- First posted
- Oct 14, 2022
Design
- Study type
- Observational
- FDA-regulated drug
- Yes
- Who can join
- Female only
Summary
As written by the sponsor on the registry.
This is a Phase 4 observational study designed to assess the impact of Palynziq ® (pegvaliase) treatment in pregnant women with PKU and on their offspring who were exposed to pegvaliase at any time during pregnancy and breastfeeding.
Conditions
- Phenylketonuria, Maternal
Interventions
PegvaliaseDrug
Pregnant women exposed to pegvaliase within 2 weeks prior to LMP.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pregnancy outcome and infant development for women who have been treated with Palynziq (pegvaliase) within 2 weeks of their last menstrual periodTime frame: 10 years
Locations
4 sites in 4 countries. Site status is shown where the registry gives one.
Syneos Health
Wilmington, North Carolina · Recruiting
Metabolics and Genetics in Calgary (MAGIC)
Calgary, Canada · Recruiting
Universitaetsklinikum Hamburg Eppendorf
Hamburg, Germany · Recruiting
Ospedale San Paolo
Milan, Italy · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.